Cathepsin B and Its Role in Parkinson's Disease
Author Information
Author(s): Jones-Tabah Jace, He Kathy, Karpilovsky Nathan, Senkevich Konstantin, Deyab Ghislaine, Pietrantonio Isabella, Goiran Thomas, Cousineau Yuting, Nikanorova Daria, Goldsmith Taylor, del Cid Pellitero Esther, Chen Carol X.-Q., Luo Wen, You Zhipeng, Abdian Narges, Ahmad Jamil, Ruskey Jennifer A., Asayesh Farnaz, Spiegelman Dan, Fahn Stanley, Waters Cheryl, Monchi Oury, Dauvilliers Yves, Dupré Nicolas, Miliukhina Irina, Timofeeva Alla, Emelyanov Anton, Pchelina Sofya, Greenbaum Lior, Hassin-Baer Sharon, Alcalay Roy N., Milnerwood Austen, Durcan Thomas M., Gan-Or Ziv
Primary Institution: McGill University
Hypothesis
Variants in the CTSB gene are associated with increased risk of Parkinson’s disease and influence lysosomal function.
Conclusion
The reduction of catB function negatively impacts lysosomal pathways associated with Parkinson's disease pathogenesis, while catB activation promotes the clearance of pathogenic alpha-synuclein.
Supporting Evidence
- Variants in the CTSB gene are significantly associated with risk of Parkinson's disease.
- CatB inhibition impairs autophagy and reduces glucocerebrosidase activity.
- Reduction of CTSB gene expression impairs the degradation of pre-formed alpha-synuclein fibrils.
- CTSB gene activation enhances fibril clearance.
- CatB inhibition potentiates the formation of inclusions that stain positively for phosphorylated alpha-synuclein.
Takeaway
Cathepsin B helps clean up bad proteins in the brain, and when it doesn't work well, it can lead to problems like Parkinson's disease.
Methodology
The study involved genetic analyses of CTSB variants, manipulation of catB expression in cell lines and dopaminergic neurons, and assessment of lysosomal activity.
Potential Biases
Potential biases may arise from the selection of cohorts and the genetic analysis methods used.
Limitations
The study's findings should be interpreted with caution due to the complexity of genetic interactions and the potential for confounding factors.
Participant Demographics
The study included 5,801 Parkinson's disease cases and 20,427 controls, primarily of European ancestry.
Statistical Information
P-Value
3.41E-16
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website